Peer-to-Peer Support Program in Improving Quality of Life Outcomes in Patients With Gynecologic Cancer and Their Caregivers



Status:Terminated
Conditions:Ovarian Cancer, Women's Studies
Therapuetic Areas:Oncology, Reproductive
Healthy:No
Age Range:19 - Any
Updated:5/12/2018
Start Date:July 2015
End Date:April 2018

Use our guide to learn which trials are right for you!

Quality of Life Outcomes From a Peer-to-Peer Support Program for Women With Gynecologic Cancer

This pilot clinical trial studies a peer-to-peer support program in improving quality of life
outcomes in patients with gynecologic cancer and their caregivers. Peer-to-peer support and
mentoring may help improve quality of life and reduce symptoms of distress in gynecologic
cancer patients and their families.

PRIMARY OBJECTIVES:

I. To test the feasibility and acceptability of a Woman-to-Woman (W2W) program for patients
with gynecologic cancer at City of Hope (COH). Address the following descriptive research
questions: were patients, mentors, and patients' family caregivers satisfied with the timing,
format, and content of the program? Did the program benefit patients, mentors, and patients'
family caregivers?

OUTLINE:

Patients participate in the W2W program for which they are matched with a trained mentor and
followed throughout treatment by phone, email, and/or in person.

After completion of study, patients are followed up at 6 and 12 months.

Inclusion Criteria:

- PATIENT PARTICIPANTS

- Patients with newly diagnosed or recurrent gynecologic cancer (ovarian, uterine,
cervical, vaginal, vulvar) actively undergoing treatment (chemotherapy, surgery, or
radiation therapy) at COH (including Duarte and South Pasadena campuses)

- English-speaking patients

- PEER MENTORS

- Peer mentors will be past gynecologic cancer patients not currently undergoing
treatment for their cancer, and considered without evidence of disease

- Over age 18

- PEER MENTORS: English-speaking patients

- This study is open to patients of all races and ethnicities

Exclusion Criteria:

- PEER MENTORS:

- Major psychiatric disease

- Currently undergoing treatment for active gynecologic cancer
We found this trial at
1
site
Duarte, California 91010
Principal Investigator: Thanh H. Dellinger, MD
Phone: 800-826-4673
?
mi
from
Duarte, CA
Click here to add this to my saved trials